Biotech pharma

Evolvere BioSciences

Website

🦠🤖 We use our computational models to make next-generation antibiotics that outcompete bacterial evolution and precisely target pathogenic bacteria, without harming good microbes or human cells. ☠️ Current antibiotics stop working because bacteria evolve resistance to them. This makes drug-resistant bacteria a looming global health crisis - alr

Founded 2021Origin source ↗Checked 2026-09-15

Overview

🦠🤖 We use our computational models to make next-generation antibiotics that outcompete bacterial evolution and precisely target pathogenic bacteria, without harming good microbes or human cells.

☠️ Current antibiotics stop working because bacteria evolve resistance to them. This makes drug-resistant bacteria a looming global health crisis - already killing more people than malaria and AIDS and it is getting exponentially worse 📈.

🧬 Our approach leverages co-evolutionary protein-protein interaction datasets combined with AI to forecast bacterial mutations and create ‘future-proof’ antibiotics, addressing antibiotic resistance before it develops. This changes the game for how frequently society will need to make new antibiotics and how long our new antibiotics will be able to treat patients 👩‍⚕️.

We are a team of biochemists and evolutionary biologists who met at the University of Oxford.

Company description As recorded 2026-11-08
Biotech pharmaBusinessesEnterpriseLicensing

Founders & team

Adam Winnifrith

Founder/CEO

Evolvere (S24), CEO & Co-Founder, MBioChem Oxford, I work at the intersection of bioengineering, protein AI, and automation. E.S.B

LinkedIn
Founder profile As recorded 2026-09-15

Piotr Jedryszek

Founder/CTO

S24, Evolvere Biosciences, CTO and Co-founder, background in Bio and CompBio

LinkedIn
Founder profile As recorded 2026-09-15
3team members reported
Source-reported As recorded 2026-09-15

Founded 2021 · Source

News & product activity

Sources & observations

Y Combinator

Profile depthverified profile
Website observationwebsite unreachable
Last website check2026-11-11
Location · source statedOxford, England, United Kingdom
Pricing evidenceNo pricing page confirmed
Maturity: Not assessed · 3 of 6 areas documented

Source-based assessment · automated evidence rules

The latest website check does not confirm this company’s website.

Maturity is an evidence-based assessment, not a success rating. It may understate the current stage where evidence is limited. Coverage records documented areas, not a complete or independently audited company history.

Stage definitions
independent websitesource corroborationdescriptive evidenceclassified market and modelsourced peoplesourced founding year
startup.observe Directory coverage · Sources & method